“Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta-analysis”

Narisa Ruenroengbun, Pawin Numthavaja, Tunlanut Sapankaew, Kamolpat Chaiyakittisopon, Atiporn Ingsathit, Gareth J Mckay, John Attia, Ammarin Thakkinstian

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: Cytomegalovirus (CMV) infection is common in kidney transplantation (KT). Antiviral-agents are used as universal prophylaxis. Our purpose aimed to compare and rank efficacy and safety.

METHOD: MEDLINE, Embase, SCOPUS, and CENTRAL were used from inception to September 2020 regardless language restriction. We included randomized clinical trials (RCTs) comparing the CMV infection/disease prophylaxis among antiviral-agents in adult KT recipients.

RESULT: Of 24 eligible RCTs, prophylactic valganciclovir could significantly lower the overall CMV infection and disease risks than placebo with pooled risk differences (RDs) (95% confidence interval (CI)) of -0.36(-0.54, -0.18) and -0.28(-0.48, -0.08), respectively. Valacyclovir and ganciclovir significantly decreased risks with the corresponding RDs of -0.25(-0.32, -0.19) and -0.30(-0.37, -0.22) for CMV infection and -0.26(-0.40, -0.12) and -0.22(-0.31, -0.12) for CMV disease. For subgroup analysis by seropositive-donor and seronegative-recipient (D+/R-), valganciclovir and ganciclovir significantly lowered the risk of CMV infection/disease with RDs of -0.42 (-0.84, -0.01) and -0.35 (-0.60, -0.12). For pre-emptive strategies, ganciclovir lowered the incidence of CMV disease significantly with pooled RDs of -0.33 (-0.47, -0.19).

CONCLUSIONS: Valganciclovir may be the best in prophylaxis of CMV infection/disease follow by ganciclovir. Valacyclovir might be an alternative where valganciclovir and ganciclovir are not available.

Original languageEnglish
JournalTransplant international : official journal of the European Society for Organ Transplantation
Early online date27 Sep 2021
DOIs
Publication statusEarly online date - 27 Sep 2021

Bibliographical note

This article is protected by copyright. All rights reserved.

Fingerprint

Dive into the research topics of '“Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta-analysis”'. Together they form a unique fingerprint.

Cite this